Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
167.4 on (proper) LSE
Seems a completely necessary step and definitely not a thinly disguised bit of marketing ;-)
So the horse is out of the bag?
“Some really credible people said something that they later said they shouldn’t. Nudge nudge, wink wink, a nods as good as a wink to a blind bat ;-)”
It removes the last real risk to the share price until P3 results. I’m guessing many are waiting on the sidelines incase Activ 2 impacts negatively like P2 Hometrial. Clearly confidence in our own P3 is higher because of the stonking results in P2 and the more recent coverage on breathless patients. If that’s the next big bit of news it is easier to invest.
*on
In a rumour?!
The odds of the science working are not impacted by time. We wouldn't kick ourselves out of our own trial of course, and we could yet be dropped from Activ 2.
I think that second point is the lagging factor here. I personally think we'll progress to P3 on Activ 2, but the results will be an indicator rather than a barnstormer because that trial is not particularly targetted in SNG001s favour.
SNG's own P3 is the big ticket. I once thought that was Activ 2 but being on a platform trial has disadvantages and it is not exactly moving quickly is it?!
This BB has gone to ****. I almost miss Scinv and Eva...
Mr Whitty warned Brits would have to live with hospitalisations and deaths "for the rest of our lives".
What a market for SNG to fill and how many lives could still be saved!
SAGE member Andrew Haywood stated that vaccines are never 100% effective on Andrew Marr this morning, when questioned on how 12 of the 42 people who’ve died from Delta in the U.K. so far are now confirmed as having had two jabs.
Almost 30%. On a variant that is now being touted as 60% more transmissible and twice as likely to result in hospitalisation.
No wonder they’re worried. Countries with even lower vaccination rates must be ****ting themselves.
Every time you respond the negative titles they write swamp the board.
Would you argue with a loon barking at the moon in a bus stop? No, so why do it on here?!
Just ignore them until their shifts finish.
...and what your risk appetite is!
The difference between doing some research and investing vs. trading. Both valid approaches to the market, but you should consider where your skills are.
I gave up on those last July! Could happen of course, especially if an Indian in vitro RNS landed just as cases started to spike across the globe
Lots of potential positives to come in the next weeks and months, any of which could accelerate timelines to revenue;
Activ 2 graduation to P3
EU therapeutics shortlist
U.K. therapeutics task force involvement
Interim P3 results
Indian variant in vitro
Take over
Have I missed anything?
Anyone know if this is normal for this type of AIM share?
Or could this be the vehicle that lets a partner buy in?
Yesterday, the derampers seemed so far away
Now they’re back with lots of tosh to say
Makes investors want to hide away
Why can’t the SP rise like yesterday
Suddenly, an RNS on Activ 2 P3
From a Dr calls himself Davey
Or we’re in the EU’s top three
News can come, so suddenly
Why Scinv had to go I don’t know, he didn’t say
Is he paid to post, or just idle in the da-a-a-y
Yesterday, new investors came to play
Hiding from Amigo’s pain all day
Now some of them have died away
Oh I believe in yesterday
Why Scinv had to g....
This is fantastic coverage right from the very heart of Activ 2.
Interesting comment on monoclonal antibodies impact expiring against variants also given our RNS yesterday!
I understand that, my exagerated point is that if you break confidence in the patent system as the mechanism for protecting investment in pharma the landscape will not be the same again, regardless of the reason for doing it.
Politicals vs. commercial reality. It will be interesting to see if this gains any traction.
One of the articles you posted seemed to hint at then needing buy-in from ALL countries. Is that true?